Celltrion’s blood cancer medicine Truxima (Celltrion) Celltrion’s Truxima, a leading **blood cancer treatment**, has achieved a significant...
Biosimilar
The launch event for Celltrion’s autoimmune disease treatment Omlyclo in Brazil (Celltrion) Celltrion announced Tuesday the official...
(Celltrion) Celltrion announced Friday that it has received product approval from the Japanese Ministry of Health, Labor...
Celltrion Celltrion announced on Friday that it will immediately implement the newly eased US biosimilar development rules...